About Mission Bio
Mission Bio is a company based in San Francisco (United States) founded in 2014 by Adam Sciambi and Charlie Silver. Mission Bio has raised $110 million across 13 funding rounds from investors including LabCorp, Agilent and HHS. Mission Bio operates in a competitive market with competitors including 10X Genomics, Singleron, Cellares, LUMICKS and LevitasBio, among others.
- Headquarter San Francisco, United States
- Founders Adam Sciambi, Charlie Silver
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mission Bio, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$110 M (USD)
in 13 rounds
-
Latest Funding Round
Not available
-
Investors
LabCorp
& 15 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Mission Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Mission Bio
Mission Bio has successfully raised a total of $110M across 13 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Mission Bio
Mission Bio has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, Agilent and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Mayfield is focused on AI innovation and venture capital investments.
|
Locked | Locked | Locked |
Investor details for Mission Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mission Bio
Investment portfolio details for Mission Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mission Bio
Detailed financials for Mission Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mission Bio Comparisons
Peer comparison for Mission Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mission Bio
Mission Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Singleron, Cellares, LUMICKS and LevitasBio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Instrument systems for genomic research and sequencing libraries are developed.
|
|
| Locked | Locked | Locked |
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis
|
|
| Locked | Locked | Locked |
Medical devices for cell-based therapy manufacturing are produced.
|
|
| Locked | Locked | Locked |
Optical tweezers instruments for single-molecule analysis are manufactured.
|
|
| Locked | Locked | Locked |
Single-cell imaging platform developed via magnetic levitation technology.
|
Detailed competitors of Mission Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mission Bio
Complete news archive for Mission Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mission Bio
Mission Bio was founded in 2014.
Mission Bio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Brian Kim is the current CEO of Mission Bio.
Mission Bio is a funded company, having raised a total of $110M across 13 funding rounds to date.
Mission Bio was founded in 2014 in San Francisco, United States, within the biotechnology sector. A single-cell multi-omics platform is developed for genotypic and phenotypic analysis, focusing on cancer applications. The Tapestri platform is employed to detect single nucleotide variants, copy number variations, and proteins concurrently. DNA and protein panels are supplied, alongside Pharma Assay Development services for pharmaceutical needs. Operations are centered in the United States.
Mission Bio's top competitors include 10X Genomics, Cellares and LUMICKS.
Mission Bio has 16 investors. Key investors include LabCorp, Agilent, HHS, National Cancer Institute, and NHGRI.